@article{O_Chogtu_Patil_2016, title={A CASE REPORT OF NADROPARIN INDUCED HYPERKALEMIA}, volume={9}, url={https://journals.innovareacademics.in/index.php/ajpcr/article/view/13115}, abstractNote={<p>ABSTRACT<br />Nadroparin, a low molecular weight heparin, has prophylactic and therapeutic use in thromboembolic disorder. In a patient with carcinoma ovary<br />stage 3 B, nadroparin was given prophylactically for deep vein thrombosis (DVT) before and after interval cytoreduction surgery. Nadroparin 0.3 ml<br />was given subcutaneously once daily for 1 day preoperatively and 8 days postoperatively. Rise in serum potassium was observed on the third postoperative<br />day<br />suggestive<br />of hyperkalemia.<br />Intravenous<br />fluids were<br />given,<br />and the<br />drug was<br />stopped<br />on the 9<br /> post-operative day and hyperkalemia<br />resolved after 2 days. Monitoring of serum potassium level is essential when Nadroparin is administered prophylactically for more than 7 days for<br />DVT. As this case illustrates a causal relationship between nadroparin and hyperkalemia, caution must be exercised with nadroparin.<br />Keywords: Nadroparin, Hyperkalemia, Thrombosis.<br />th</p>}, number={7}, journal={Asian Journal of Pharmaceutical and Clinical Research}, author={O, Balaji and Chogtu, Bharti and Patil, Navin}, year={2016}, month={Aug.}, pages={3–4} }